KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Assets (2019 - 2025)

Historic Return on Assets for Moderna (MRNA) over the last 7 years, with Q3 2025 value amounting to 0.26%.

  • Moderna's Return on Assets fell 1200.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.22% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Moderna's Return on Assets stood at 0.26%, which was down 1200.0% from 0.23% recorded in Q2 2025.
  • Moderna's Return on Assets' 5-year high stood at 0.56% during Q1 2022, with a 5-year trough of 0.36% in Q2 2024.
  • Its 5-year average for Return on Assets is 0.06%, with a median of 0.05% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 6600bps in 2021, then crashed by -6200bps in 2023.
  • Quarter analysis of 5 years shows Moderna's Return on Assets stood at 0.54% in 2021, then crashed by -40bps to 0.32% in 2022, then tumbled by -177bps to 0.25% in 2023, then rose by 4bps to 0.24% in 2024, then dropped by -9bps to 0.26% in 2025.
  • Its Return on Assets stands at 0.26% for Q3 2025, versus 0.23% for Q2 2025 and 0.25% for Q1 2025.